1.
Ruymann FB, et al. Rhabdomyosarcoma and related tumors in children and adolescents. Epidemiology of soft tissues sarcomas. In: Maurer HM RF, Pochedly C, editors. Boca Raton: CRC Press; 1991.
2.
Gurney JG YJ, Roffers SD, et al. Soft tissue sarcomas. Gloecker Ries IA SM, Gurney JG, et al, editor. United States SEER program 1975–1995. 1999.
3.
Ferrari A, Sultan I, Huang TT, Rodriguez-Galindo C, Shehadeh A, Meazza C, et al. Soft tissue sarcoma across the age spectrum: a population-based study from the surveillance epidemiology and end results database. Pediatr Blood Cancer. 2011;57(6):943–9.
PubMedPubMedCentralCrossRef
4.
Ries LAG SM, Gurney JG, et al. Cancer incidence and survival among children and adolescents: United States SEER Program 1975–1995. National Cancer Institute, SEER Program NIH Pub No 99–4649 Bethesda; 1999.
5.
Hayes-Jordan AA, Spunt SL, Poquette CA, Cain AM, Rao BN, Pappo AS, et al. Nonrhabdomyosarcoma soft tissue sarcomas in children: is age at diagnosis an important variable? J Pediatr Surg. 2000;35(6):948–53; discussion 953–4. PubMed Epub 2000/06/29. eng.
PubMedCrossRef
6.
Linabery AM, Ross JA. Trends in childhood cancer incidence in the U.S. (1992–2004). Cancer. 2008;112(2):416–32.
PubMedCrossRef
7.
Li FP, Fraumeni JF, Mulvihill JJ, Blattner WA, Dreyfus MG, Tucker MA, et al. A cancer family syndrome in twenty-four kindreds. Cancer Res. 1988;48(18):5358–62.
PubMed
8.
Kleinerman RA, Tucker MA, Abramson DH, Seddon JM, Tarone RE, Fraumeni Jr JF. Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma. J Natl Cancer Inst. 2007;99(1):24–31. PubMed Epub 2007/01/05. eng.
PubMedCrossRef
9.
Sorensen SA, Mulvihill JJ, Nielsen A. Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms. N Engl J Med. 1986;314(16):1010–5. PubMed Epub 1986/04/17. eng.
PubMedCrossRef
10.
Gorlin RJ. Nevoid basal cell carcinoma (Gorlin) syndrome. Genet Med Off J Am College Med Genet. 2004;6(6):530–9. PubMed Epub 2004/11/17. eng.
11.
Goto M, Miller RW, Ishikawa Y, Sugano H. Excess of rare cancers in Werner syndrome (adult progeria). Cancer Epidemiol Biomarkers Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. 1996;5(4):239–46. PubMed Epub 1996/04/01. eng.
12.
Malkin D. p53 and the Li-Fraumeni syndrome. Cancer Genet Cytogenet. 1993;66(2):83–92. PubMed Epub 1993/04/01. eng.
PubMedCrossRef
13.
Malkin D, Li FP, Strong LC, Fraumeni Jr JF, Nelson CE, Kim DH, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science. 1990;250(4985):1233–8. PubMed Epub 1990/12/10. eng.
PubMedCrossRef
14.
Glover TW, Stein CK, Legius E, Andersen LB, Brereton A, Johnson S. Molecular and cytogenetic analysis of tumors in von Recklinghausen neurofibromatosis. Genes Chromosomes Cancer. 1991;3(1):62–70. PubMed Epub 1991/01/01. eng.
PubMedCrossRef
15.
Ducatman BS, Scheithauer BW, Piepgras DG, Reiman HM, Ilstrup DM. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer. 1986;57(10):2006–21. PubMed Epub 1986/05/15. eng.
PubMedCrossRef
16.
Evans DG, Baser ME, McGaughran J, Sharif S, Howard E, Moran A. Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet. 2002;39(5):311–4. PubMed Pubmed Central PMCID: 1735122. Epub 2002/05/16. eng.
PubMedPubMedCentralCrossRef
17.
Neville HL, Seymour-Dempsey K, Slopis J, Gill BS, Moore BD, Lally KP, et al. The role of surgery in children with neurofibromatosis. J Pediatr Surg. 2001;36(1):25–9. PubMed Epub 2001/01/11. eng.
PubMedCrossRef
18.
Neville H, Corpron C, Blakely ML, Andrassy R. Pediatric neurofibrosarcoma. J Pediatr Surg. 2003;38(3):343–6; discussion 343–6. PubMed Epub 2003/03/13. eng.
PubMedCrossRef
19.
Clark SK, Neale KF, Landgrebe JC, Phillips RK. Desmoid tumours complicating familial adenomatous polyposis. Br J Surg. 1999;86(9):1185–9. PubMed Epub 1999/10/03. eng.
PubMedCrossRef
20.
Gurbuz AK, Giardiello FM, Petersen GM, Krush AJ, Offerhaus GJ, Booker SV, et al. Desmoid tumours in familial adenomatous polyposis. Gut. 1994;35(3):377–81. PubMed Pubmed Central PMCID: 1374594. Epub 1994/03/01. eng.
PubMedPubMedCentralCrossRef
21.
Heiskanen I, Jarvinen HJ. Occurrence of desmoid tumours in familial adenomatous polyposis and results of treatment. Int J Colorectal Dis. 1996;11(4):157–62. PubMed Epub 1996/01/01. eng.
PubMedCrossRef
22.
McClain KL, Leach CT, Jenson HB, Joshi VV, Pollock BH, Parmley RT, et al. Association of Epstein–Barr virus with leiomyosarcomas in young people with AIDS. N Engl J Med. 1995;332(1):12–8.
PubMedCrossRef
23.
Stewart FW, Treves N. Classics in oncology: lymphangiosarcoma in postmastectomy lymphedema: a report of six cases in elephantiasis chirurgica. CA Cancer J Clin. 1981;31(5):284–99. PubMed Epub 1981/09/01. eng.
PubMedCrossRef
24.
Laskin WB, Silverman TA, Enzinger FM. Postradiation soft tissue sarcomas. An analysis of 53 cases. Cancer. 1988;62(11):2330–40. PubMed Epub 1988/12/01. eng.
PubMedCrossRef
25.
Cha C, Antonescu CR, Quan ML, Maru S, Brennan MF. Long-term results with resection of radiation-induced soft tissue sarcomas. Ann Surg. 2004;239(6):903–9; discussion 909–10. PubMed Pubmed Central PMCID: 1356299. Epub 2004/05/29. eng.
PubMedPubMedCentralCrossRef
26.
Spunt SL, Skapcek SX, Coffin CM. Pediatric nonrhabdomyosarcoma soft tissue sarcomas. Oncologist. 2008;13(6):668–78. PubMed Epub 2008/07/01. eng.
PubMedCrossRef
27.
Ferrari A, Miceli R, Casanova M, Meazza C, Favini F, Luksch R, et al. The symptom interval in children and adolescents with soft tissue sarcomas. Cancer. 2010;116(1):177–83. PubMed Epub 2009/10/29. eng.
PubMed
28.
Pappo AS, Rao BN, Jenkins JJ, Merchant T, Poquette CA, Cain A, et al. Metastatic nonrhabdomyosarcomatous soft-tissue sarcomas in children and adolescents: the St. Jude Children’s Research Hospital experience. Med Pediatr Oncol. 1999;33(2):76–82. PubMed Epub 1999/07/09. eng.
PubMedCrossRef
29.
Heslin MJ, Lewis JJ, Woodruff JM, Brennan MF. Core needle biopsy for diagnosis of extremity soft tissue sarcoma. Ann Surg Oncol. 1997;4(5):425–31. PubMed Epub 1997/07/01. eng.
PubMedCrossRef
30.
Chowdhury T, Barnacle A, Haque S, Sebire N, Gibson S, Anderson J, et al. Ultrasound-guided core needle biopsy for the diagnosis of rhabdomyosarcoma in childhood. Pediatr Blood Cancer. 2009;53(3):356–60.
PubMedCrossRef
31.
Chui CH. Nonrhabdomyosarcoma soft tissue sarcoma (NRSTS). Surg Oncol. 2007;16(3):187–93.
PubMedCrossRef
32.
Pappo AS, Devidas M, Jenkins J, Rao B, Marcus R, Thomas P, et al. Phase II trial of neoadjuvant vincristine, ifosfamide, and doxorubicin with granulocyte colony-stimulating factor support in children and adolescents with advanced-stage nonrhabdomyosarcomatous soft tissue sarcomas: a Pediatric Oncology Group Study. J Clin Oncol Off J Am Soc Clin Oncol. 2005;23(18):4031–8. PubMed Epub 2005/03/16. eng.
CrossRef
33.
Pratt CB, Maurer HM, Gieser P, Salzberg A, Rao BN, Parham D, et al. Treatment of unresectable or metastatic pediatric soft tissue sarcomas with surgery, irradiation, and chemotherapy: a Pediatric Oncology Group study. Med Pediatr Oncol. 1998;30(4):201–9. PubMed Epub 1998/02/25. eng.
PubMedCrossRef
34.
Pratt CB, Pappo AS, Gieser P, Jenkins JJ, Salzbergdagger A, Neff J, et al. Role of adjuvant chemotherapy in the treatment of surgically resected pediatric nonrhabdomyosarcomatous soft tissue sarcomas: A Pediatric Oncology Group Study. J Clin Oncol Off J Am Soc Clin Oncol. 1999;17(4):1219. PubMed Epub 1999/11/24. eng.
35.
Spunt SL, Poquette CA, Hurt YS, Cain AM, Rao BN, Merchant TE, et al. Prognostic factors for children and adolescents with surgically resected nonrhabdomyosarcoma soft tissue sarcoma: an analysis of 121 patients treated at St Jude Children’s Research Hospital. J Clin Oncol Off J Am Soc Clin Oncol. 1999;17(12):3697–705. PubMed Epub 1999/11/30. Eng.
36.
Marcus KC, Grier HE, Shamberger RC, Gebhardt MC, Perez-Atayde A, Silver B, et al. Childhood soft tissue sarcoma: a 20-year experience. J Pediatr. 1997;131(4):603–7. PubMed Epub 1997/12/05. eng.
PubMedCrossRef
37.
Stojadinovic A, Leung DH, Allen P, Lewis JJ, Jaques DP, Brennan MF. Primary adult soft tissue sarcoma: time-dependent influence of prognostic variables. J Clin Oncol Off J Am Soc Clin Oncol. 2002;20(21):4344–52. PubMed Epub 2002/11/01. eng.
CrossRef
38.
Maurer HM, Beltangady M, Gehan EA, Crist W, Hammond D, Hays DM, et al. The intergroup rhabdomyosarcoma study-I. A final report. Cancer. 1988;61(2):209–20. PubMed Epub 1988/01/15. eng.
PubMedCrossRef
39.
Edge SB BD, Compton CC, et al., eds. Soft tissue sarcoma. AJCC cancer staging manual. 7th ed. Springer New York, NY; 2010.
40.
Hajdu SI, Shiu MH, Brennan MF. The role of the pathologist in the management of soft tissue sarcomas. World J Surg. 1988;12(3):326–31. PubMed Epub 1988/06/01. eng.
PubMedCrossRef
41.
Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. 1980. Clin Orthop Relat Res. 2003;(415):4–18. PubMed: 14612624. Epub 2003/11/13. eng.
42.
Costa J, Wesley RA, Glatstein E, Rosenberg SA. The grading of soft tissue sarcomas. Results of a clinicohistopathologic correlation in a series of 163 cases. Cancer. 1984;53(3):530–41. PubMed Epub 1984/02/01. eng.
PubMedCrossRef
43.
Parham DM, Webber BL, Jenkins 3rd JJ, Cantor AB, Maurer HM. Nonrhabdomyosarcomatous soft tissue sarcomas of childhood: formulation of a simplified system for grading. Mod Pathol Off J U S Can Acad Pathol Inc. 1995;8(7):705–10. PubMed Epub 1995/09/01. eng.
44.
Guillou L, Coindre JM, Bonichon F, Nguyen BB, Terrier P, Collin F, et al. Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol Off J Am Soc Clin Oncol. 1997;15(1):350–62. PubMed Epub 1997/01/01. eng.
45.
Coindre JM, Trojani M, Contesso G, David M, Rouesse J, Bui NB, et al. Reproducibility of a histopathologic grading system for adult soft tissue sarcoma. Cancer. 1986;58(2):306–9. PubMed Epub 1986/07/15. eng.
PubMedCrossRef
46.
Khoury JD, Coffin CM, Spunt SL, Anderson JR, Meyer WH, Parham DM. Grading of nonrhabdomyosarcoma soft tissue sarcoma in children and adolescents: a comparison of parameters used for the Federation Nationale des Centers de Lutte Contre le Cancer and Pediatric Oncology Group Systems. Cancer. 2010;116(9):2266–74. PubMed Pubmed Central PMCID: 2987713. Epub 2010/02/19. eng.
PubMedPubMedCentral
47.
Butler MS, Robertson WW, Jr., Rate W, D’Angio GJ, Drummond DS. Skeletal sequelae of radiation therapy for malignant childhood tumors. Clin Orthop Relat Res. 1990;(251):235–40. PubMed: 2136823. Epub 1990/02/01. eng.
48.
Smith MB, Xue H, Strong L, Takahashi H, Jaffe N, Ried H, et al. Forty-year experience with second malignancies after treatment of childhood cancer: analysis of outcome following the development of the second malignancy. J Pediatr Surg. 1993;28(10):1342–8; discussion 1348–9. PubMed Epub 1993/10/01. eng.
PubMedCrossRef
49.
Humpl T, Fritsche M, Bartels U, Gutjahr P. Survivors of childhood cancer for more than twenty years. Acta Oncol. 2001;40(1):44–9. PubMed Epub 2001/04/26. eng.
PubMedCrossRef
50.
Feig SA. Second malignant neoplasms after successful treatment of childhood cancers. Blood Cells Mol Dis. 2001;27(3):662–6. PubMed Epub 2001/08/03. eng.
PubMedCrossRef
51.
Rich DC, Corpron CA, Smith MB, Black CT, Lally KP, Andrassy RJ. Second malignant neoplasms in children after treatment of soft tissue sarcoma. J Pediatr Surg. 1997;32(2):369–72. PubMed Epub 1997/02/01. eng.
PubMedCrossRef
52.
Moller TR, Garwicz S, Barlow L, Falck Winther J, Glattre E, Olafsdottir G, et al. Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: a population-based study in the Nordic countries. J Clin Oncol Off J Am Soc Clin Oncol. 2001;19(13):3173–81. PubMed Epub 2001/07/04. eng.
53.
Corpron CA, Black CT, Ross MI, Herzog CS, Ried HL, Lally KP, et al. Melanoma as a second malignant neoplasm after childhood cancer. Am J Surg. 1996;172(5):459–61; discussion 461–2. PubMed Epub 1996/11/01. eng.
PubMedCrossRef
54.
Miller SD, Andrassy RJ. Complications in pediatric surgical oncology. J Am Coll Surg. 2003;197(5):832–7. PubMed Epub 2003/10/31. eng.
PubMedCrossRef
55.
Ferrari A, Miceli R, Meazza C, Zaffignani E, Gronchi A, Piva L, et al. Soft tissue sarcomas of childhood and adolescence: the prognostic role of tumor size in relation to patient body size. J Clin Oncol Off J Am Soc Clin Oncol. 2009;27(3):371–6. PubMed Epub 2008/12/10. eng.
CrossRef
56.
Hayes-Jordan A. Recent advances in non-rhabdomyosarcoma soft-tissue sarcomas. Semin Pediatr Surg. 2012;21(1):61–7. PubMed Epub 2012/01/18. eng.
PubMedCrossRef
57.
Davis AM, Kandel RA, Wunder JS, Unger R, Meer J, O’Sullivan B, et al. The impact of residual disease on local recurrence in patients treated by initial unplanned resection for soft tissue sarcoma of the extremity. J Surg Oncol. 1997;66(2):81–7. PubMed Epub 1997/11/14. eng.
PubMedCrossRef
58.
Blakely ML, Spurbeck WW, Pappo AS, Pratt CB, Rodriguez-Galindo C, Santana VM, et al. The impact of margin of resection on outcome in pediatric nonrhabdomyosarcoma soft tissue sarcoma. J Pediatr Surg. 1999;34(5):672–5. PubMed Epub 1999/06/08. eng.
PubMedCrossRef
59.
Chui CH, Spunt SL, Liu T, Pappo AS, Davidoff AM, Rao BN, et al. Is reexcision in pediatric nonrhabdomyosarcoma soft tissue sarcoma necessary after an initial unplanned resection? J Pediatr Surg. 2002;37(10):1424–9.
PubMedCrossRef
60.
Sultan I, Rodriguez-Galindo C, Saab R, Yasir S, Casanova M, Ferrari A. Comparing children and adults with synovial sarcoma in the Surveillance, Epidemiology, and End Results program, 1983 to 2005: an analysis of 1268 patients. Cancer. 2009;115(15):3537–47. PubMed Epub 2009/06/11. eng.
PubMedCrossRef
61.
Daigeler A, Kuhnen C, Moritz R, Stricker I, Goertz O, Tilkorn D, et al. Lymph node metastases in soft tissue sarcomas: a single center analysis of 1,597 patients. Langenbecks Arch Surg/Deutsche Gesellschaft fur Chirurgie. 2009;394(2):321–9. PubMed Epub 2008/07/03. eng.
CrossRef
62.
Kayton ML, Delgado R, Busam K, Cody 3rd HS, Athanasian EA, Coit D, et al. Experience with 31 sentinel lymph node biopsies for sarcomas and carcinomas in pediatric patients. Cancer. 2008;112(9):2052–9. PubMed Epub 2008/03/15. eng.
PubMedCrossRef
63.
De Corti F, Dall’Igna P, Bisogno G, Casara D, Rossi CR, Foletto M, et al. Sentinel node biopsy in pediatric soft tissue sarcomas of extremities. Pediatr Blood Cancer. 2009;52(1):51–4. PubMed Epub 2008/09/27. eng.
PubMedCrossRef
64.
Neville HL, Andrassy RJ, Lally KP, Corpron C, Ross MI. Lymphatic mapping with sentinel node biopsy in pediatric patients. J Pediatr Surg. 2000;35(6):961–4. PubMed Epub 2000/06/29. eng.
PubMedCrossRef
65.
Al-Refaie WB, Andtbacka RH, Ensor J, Pisters PW, Ellis TL, Shrout A, et al. Lymphadenectomy for isolated lymph node metastasis from extremity soft-tissue sarcomas. Cancer. 2008;112(8):1821–6. PubMed Epub 2008/02/29. eng.
PubMedCrossRef
66.
Riad S, Griffin AM, Liberman B, Blackstein ME, Catton CN, Kandel RA, et al. Lymph node metastasis in soft tissue sarcoma in an extremity. Clin Orthop Relat Res. 2004;(426):129–34. PubMed: 15346063. Epub 2004/09/04. eng.
67.
Cheung MC, Zhuge Y, Yang R, Ogilvie MP, Koniaris LG, Rodriguez MM, et al. Incidence and outcomes of extremity soft-tissue sarcomas in children. J Surg Res. 2010;163(2):282–9. PubMed Epub 2010/07/20. eng.
PubMedCrossRef
68.
van Geel AN, Pastorino U, Jauch KW, Judson IR, van Coevorden F, Buesa JM, et al. Surgical treatment of lung metastases: The European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group study of 255 patients. Cancer. 1996;77(4):675–82. PubMed Epub 1996/02/15. eng.
PubMedCrossRef
69.
Billingsley KG, Burt ME, Jara E, Ginsberg RJ, Woodruff JM, Leung DH, et al. Pulmonary metastases from soft tissue sarcoma: analysis of patterns of diseases and postmetastasis survival. Ann Surg. 1999;229(5):602–10; discussion 610–2. PubMed Pubmed Central PMCID: 1420804. Epub 1999/05/11. eng.
PubMedPubMedCentralCrossRef
70.
Predina JD, Puc MM, Bergey MR, Sonnad SS, Kucharczuk JC, Staddon A, et al. Improved survival after pulmonary metastasectomy for soft tissue sarcoma. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. 2011;6(5):913–9. PubMed Epub 2011/07/14. eng.
71.
Gossot D, Radu C, Girard P, Le Cesne A, Bonvalot S, Boudaya MS, et al. Resection of pulmonary metastases from sarcoma: can some patients benefit from a less invasive approach? Ann Thorac Surg. 2009;87(1):238–43. PubMed Epub 2008/12/23. eng.
PubMedCrossRef
72.
Weiser MR, Downey RJ, Leung DH, Brennan MF. Repeat resection of pulmonary metastases in patients with soft-tissue sarcoma. J Am Coll Surg. 2000;191(2):184–90; discussion 190–1. PubMed Epub 2000/08/17. eng.
PubMedCrossRef
73.
Temeck BK, Wexler LH, Steinberg SM, McClure LL, Horowitz MA, Pass HI. Reoperative pulmonary metastasectomy for sarcomatous pediatric histologies. Ann Thorac Surg. 1998;66(3):908–12; discussion 913. PubMed Epub 1998/10/13. eng.
PubMedCrossRef
74.
Temeck BK, Wexler LH, Steinberg SM, McClure LL, Horowitz M, Pass HI. Metastasectomy for sarcomatous pediatric histologies: results and prognostic factors. Ann Thorac Surg. 1995;59(6):1385–9; discussion 1390. PubMed Epub 1995/06/01. eng.
PubMedCrossRef
75.
Yagihashi S. Alveolar soft part sarcoma. Are we approaching the goal of determining its histogenesis? Acta Pathol Jpn. 1992;42(6):466–8. PubMed Epub 1992/06/01. eng.
PubMed
76.
Williams A, Bartle G, Sumathi VP, Meis JM, Mangham DC, Grimer RJ, et al. Detection of ASPL/TFE3 fusion transcripts and the TFE3 antigen in formalin-fixed, paraffin-embedded tissue in a series of 18 cases of alveolar soft part sarcoma: useful diagnostic tools in cases with unusual histological features. Virchows Archiv Int J Pathol. 2011;458(3):291–300. PubMed Epub 2011/02/01. eng.
CrossRef
77.
Ladanyi M. Fusions of the SYT and SSX genes in synovial sarcoma. Oncogene. 2001;20(40):5755–62. PubMed Epub 2001/10/19. eng.
PubMedCrossRef
78.
Kim YD, Lee CH, Lee MK, Jeong YJ, Kim JY, Park do Y, et al. Primary alveolar soft part sarcoma of the lung. J Korean Med Sci. 2007;22(2):369–72. PubMed Pubmed Central PMCID: 2693611. Epub 2007/04/24. eng.
PubMedPubMedCentralCrossRef
79.
Luo J, Melnick S, Rossi A, Burke RP, Pfeifer JD, Dehner LP. Primary cardiac alveolar soft part sarcoma. A report of the first observed case with molecular diagnostics corroboration. Pediatr Dev Pathol Off J Soc Pediatr Pathol Paediatr Pathol Soc. 2008;11(2):142–7. PubMed Epub 2007/03/24. eng.
CrossRef
80.
Kashyap S, Sen S, Sharma MC, Betharia SM, Bajaj MS. Alveolar soft-part sarcoma of the orbit: report of three cases. Can J Ophthalmol Journal canadien d’ophtalmologie. 2004;39(5):552–6. PubMed Epub 2004/10/20. eng.
PubMedCrossRef
81.
Hillyer S, Vicens JC, Levinson H, Bhayani R, Mesea L, Chaudhry R, et al. Alveolar soft-part sarcoma of the tongue in a 17-month-old. Ear Nose Throat J. 2009;88(10):E4–9. PubMed Epub 2009/10/15. eng.
PubMed
82.
Raney Jr RB. Proceedings of the Tumor Board of the Children’s Hospital of Philadelphia: alveolar soft-part sarcoma. Med Pediatr Oncol. 1979;6(4):367–70. PubMed Epub 1979/01/01. eng.
PubMedCrossRef
83.
Casanova M, Ferrari A, Bisogno G, Cecchetto G, Basso E, De Bernardi B, et al. Alveolar soft part sarcoma in children and adolescents: a report from the Soft-Tissue Sarcoma Italian Cooperative Group. Ann Oncol Off J Eur Soc Med Oncol/ESMO. 2000;11(11):1445–9. PubMed Epub 2001/01/06. eng.
CrossRef
84.
Machhi J, Kouzova M, Komorowski DJ, Asma Z, Chivukala M, Basir Z, et al. Crystals of alveolar soft part sarcoma in a fine needle aspiration biopsy cytology smear. A case report. Acta Cytol. 2002;46(5):904–8. PubMed Epub 2002/10/09. eng.
PubMedCrossRef
85.
Lopez-Ferrer P, Jimenez-Heffernan JA, Vicandi B, Gonzalez-Peramato P, Viguer JM. Cytologic features of alveolar soft part sarcoma: report of three cases. Diagn Cytopathol. 2002;27(2):115–9. PubMed Epub 2002/08/31. eng.
PubMedCrossRef
86.
Tsou MH, Lin HH, Chen CM. Intracytoplasmic crystals of alveolar soft part sarcoma: demonstration by Riu’s stain. Acta Cytol. 1997;41(4):1234–6. PubMed Epub 1997/07/01. eng.
PubMed
87.
Husain M, Nguyen GK. Alveolar soft part sarcoma. Report of a case diagnosed by needle aspiration cytology and electron microscopy. Acta Cytol. 1995;39(5):951–4. PubMed Epub 1995/09/01. eng.
PubMed
88.
Gupta S, Jain S, Sodhani P. Alveolar soft part sarcoma: a rare entity with unique cytomorphological features. Cytopathology Off J Br Soc Clin Cytol. 2003;14(1):40–1. PubMed Epub 2003/02/18. eng.
CrossRef
89.
Neville HL, Lally KP, Cox Jr CS. Emergent abdominal decompression with patch abdominoplasty in the pediatric patient. J Pediatr Surg. 2000;35(5):705–8. PubMed Epub 2000/05/17. eng.
PubMedCrossRef
90.
Conde N, Cruz O, Albert A, Mora J. Antiangiogenic treatment as a pre-operative management of alveolar soft-part sarcoma. Pediatr Blood Cancer. 2011;57(6):1071–3. PubMed Epub 2011/07/12. eng.
PubMedCrossRef
91.
Stacchiotti S, Tamborini E, Marrari A, Brich S, Rota SA, Orsenigo M, et al. Response to sunitinib malate in advanced alveolar soft part sarcoma. Clin Cancer Res Off J Am Assoc Cancer Res. 2009;15(3):1096–104. PubMed Epub 2009/02/04. eng.
CrossRef
92.
Azizi AA, Haberler C, Czech T, Gupper A, Prayer D, Breitschopf H, et al. Vascular-endothelial-growth-factor (VEGF) expression and possible response to angiogenesis inhibitor bevacizumab in metastatic alveolar soft part sarcoma. Lancet Oncol. 2006;7(6):521–3. PubMed Epub 2006/06/06. eng.
PubMedCrossRef
93.
Roozendaal KJ, de Valk B, ten Velden JJ, van der Woude HJ, Kroon BB. Alveolar soft-part sarcoma responding to interferon alpha-2b. Br J Cancer. 2003;89(2):243–5. PubMed Pubmed Central PMCID: 2394261. Epub 2003/07/17. eng.
PubMedPubMedCentralCrossRef
94.
Hilbert M, Mary P, Larroquet M, Serinet MO, Helfre S, Brisse H, et al. Alveolar soft part sarcoma in childhood: is Sunitinib-Sutent(R) treatment an effective approach? Pediatr Blood Cancer. 2012;58(3):475–6. PubMed Epub 2012/01/12. eng.
PubMedCrossRef
95.
Kayton ML, Huvos AG, Casher J, Abramson SJ, Rosen NS, Wexler LH, et al. Computed tomographic scan of the chest underestimates the number of metastatic lesions in osteosarcoma. J Pediatr Surg. 2006;41(1):200–6; discussion 200–6. PubMed Epub 2006/01/18. eng.
PubMedCrossRef
96.
Lieberman PH, Brennan MF, Kimmel M, Erlandson RA, Garin-Chesa P, Flehinger BY. Alveolar soft-part sarcoma. A clinico-pathologic study of half a century. Cancer. 1989;63(1):1–13. PubMed Epub 1989/01/01. eng.
PubMedCrossRef
97.
Evans HL. Alveolar soft-part sarcoma. A study of 13 typical examples and one with a histologically atypical component. Cancer. 1985;55(4):912–7. PubMed Epub 1985/02/15. eng.
PubMedCrossRef
98.
Lal DR, Su WT, Wolden SL, Loh KC, Modak S, La Quaglia MP. Results of multimodal treatment for desmoplastic small round cell tumors. J Pediatr Surg. 2005;40(1):251–5. PubMed Epub 2005/05/04. eng.
PubMedCrossRef
99.
Sawyer JR, Tryka AF, Lewis JM. A novel reciprocal chromosome translocation t(11;22)(p13;q12) in an intraabdominal desmoplastic small round-cell tumor. Am J Surg Pathol. 1992;16(4):411–6. PubMed Epub 1992/04/01. eng.
PubMedCrossRef
100.
Rodriguez E, Sreekantaiah C, Gerald W, Reuter VE, Motzer RJ, Chaganti RS. A recurring translocation, t(11;22)(p13;q11.2), characterizes intra-abdominal desmoplastic small round-cell tumors. Cancer Genet Cytogenet. 1993;69(1):17–21. PubMed Epub 1993/08/01. eng.
PubMedCrossRef
101.
Hayes-Jordan A, Anderson PM. The diagnosis and management of desmoplastic small round cell tumor: a review. Curr Opin Oncol. 2011;23(4):385–9. PubMed Epub 2011/05/18. eng.
PubMedCrossRef
102.
Zhang WD, Li CX, Liu QY, Hu YY, Cao Y, Huang JH. CT, MRI, and FDG-PET/CT imaging findings of abdominopelvic desmoplastic small round cell tumors: correlation with histopathologic findings. Eur J Radiol. 2011;80(2):269–73. PubMed Epub 2010/07/24. eng.
PubMedCrossRef
103.
Hayes-Jordan A, Green H, Fitzgerald N, Xiao L, Anderson P. Novel treatment for desmoplastic small round cell tumor: hyperthermic intraperitoneal perfusion. J Pediatr Surg. 2010;45(5):1000–6. PubMed Epub 2010/05/05. eng.
PubMedCrossRef
104.
Sultan I, Casanova M, Al-Jumaily U, Meazza C, Rodriguez-Galindo C, Ferrari A. Soft tissue sarcomas in the first year of life. Eur J Cancer. 2010;46(13):2449–56. PubMed Epub 2010/06/12. eng.
PubMedCrossRef
105.
Bourgeois JM, Knezevich SR, Mathers JA, Sorensen PH. Molecular detection of the ETV6-NTRK3 gene fusion differentiates congenital fibrosarcoma from other childhood spindle cell tumors. Am J Surg Pathol. 2000;24(7):937–46. PubMed Epub 2000/07/15. eng.
PubMedCrossRef
106.
Orbach D, Rey A, Cecchetto G, Oberlin O, Casanova M, Thebaud E, et al. Infantile fibrosarcoma: management based on the European experience. J Clin Oncol Off J Am Soc Clin Oncol. 2010;28(2):318–23. PubMed Epub 2009/11/18. eng.
CrossRef
107.
Cecchetto G, Carli M, Alaggio R, Dall’Igna P, Bisogno G, Scarzello G, et al. Fibrosarcoma in pediatric patients: results of the Italian Cooperative Group studies (1979–1995). J Surg Oncol. 2001;78(4):225–31. PubMed Epub 2001/12/18. eng.
PubMedCrossRef
108.
Loh ML, Ahn P, Perez-Atayde AR, Gebhardt MC, Shamberger RC, Grier HE. Treatment of infantile fibrosarcoma with chemotherapy and surgery: results from the Dana-Farber Cancer Institute and Children’s Hospital, Boston. J Pediatr Hematol Oncol. 2002;24(9):722–6. PubMed Epub 2002/12/07. eng.
PubMedCrossRef
109.
Black J, Coffin CM, Dehner LP. Fibrohistiocytic tumors and related neoplasms in children and adolescents. Pediatr Dev Pathol Off J Soc Pediatr Pathol Paediatr Pathol Soc. 2012;15(1 Suppl):181–210. PubMed Epub 2012/05/11. eng.
CrossRef
110.
Criscione VD, Weinstock MA. Descriptive epidemiology of dermatofibrosarcoma protuberans in the United States, 1973 to 2002. J Am Acad Dermatol. 2007;56(6):968–73. PubMed Epub 2006/12/05. eng.
PubMedCrossRef
111.
Thornton SL, Reid J, Papay FA, Vidimos AT. Childhood dermatofibrosarcoma protuberans: role of preoperative imaging. J Am Acad Dermatol. 2005;53(1):76–83. PubMed Epub 2005/06/21. eng.
PubMedCrossRef
112.
(NCCN) NCCN. NCCN Clinical Practice Guidelines in Oncology Dermatofibrosarcoma Protuberans Version 2. 2015. Available at NCCN.org. Accessed on October 12, 2015.
113.
Paradisi A, Abeni D, Rusciani A, Cigna E, Wolter M, Scuderi N, et al. Dermatofibrosarcoma protuberans: wide local excision vs. Mohs micrographic surgery. Cancer Treat Rev. 2008;34(8):728–36. PubMed Epub 2008/08/08. eng.
PubMedCrossRef
114.
Shimizu A, O’Brien KP, Sjoblom T, Pietras K, Buchdunger E, Collins VP, et al. The dermatofibrosarcoma protuberans-associated collagen type I alpha1/platelet-derived growth factor (PDGF) B-chain fusion gene generates a transforming protein that is processed to functional PDGF-BB. Cancer Res. 1999;59(15):3719–23. PubMed Epub 1999/08/14. eng.
PubMed
115.
Gooskens SL, Oranje AP, van Adrichem LN, de Waard-van der Spek FB, den Hollander JC, van de Ven CP, et al. Imatinib mesylate for children with dermatofibrosarcoma protuberans (DFSP). Pediatr Blood Cancer. 2010;55(2):369–73. PubMed Epub 2010/06/29. eng.
PubMedCrossRef
116.
Stacchiotti S, Pedeutour F, Negri T, Conca E, Marrari A, Palassini E, et al. Dermatofibrosarcoma protuberans-derived fibrosarcoma: clinical history, biological profile and sensitivity to imatinib. Int J Cancer Journal International du Cancer. 2011;129(7):1761–72. PubMed Epub 2010/12/04. eng.
PubMedCrossRef
117.
Daw NC, Billups CA, Pappo AS, Jenkins JJ, Mahmoud HH, Krasin MJ, et al. Malignant fibrous histiocytoma and other fibrohistiocytic tumors in pediatric patients: the St. Jude Children’s Research Hospital Experience. Cancer. 2003;97(11):2839–47. PubMed Epub 2003/05/27. eng.
PubMedCrossRef
118.
Cole CH, Magee JF, Gianoulis M, Rogers PC. Malignant fibrous histiocytoma in childhood. Cancer. 1993;71(12):4077–83. PubMed Epub 1993/06/15. eng.
PubMedCrossRef
119.
Tracy Jr T, Neifeld JP, DeMay RM, Salzberg AM. Malignant fibrous histiocytomas in children. J Pediatr Surg. 1984;19(1):81–3. PubMed Epub 1984/02/01. eng.
PubMedCrossRef
120.
Corpron CA, Black CT, Raney RB, Pollock RE, Lally KP, Andrassy RJ. Malignant fibrous histiocytoma in children. J Pediatr Surg. 1996;31(8):1080–3. PubMed Epub 1996/08/01. eng.
PubMedCrossRef
121.
Raney Jr RB, Allen A, O’Neill J, Handler SD, Uri A, Littman P. Malignant fibrous histiocytoma of soft tissue in childhood. Cancer. 1986;57(11):2198–201. PubMed Epub 1986/06/01. eng.
PubMedCrossRef
122.
Alaggio R, Collini P, Randall RL, Barnette P, Million L, Coffin CM. Undifferentiated high-grade pleomorphic sarcomas in children: a clinicopathologic study of 10 cases and review of literature. Pediatr Dev Pathol Off J Soc Pediatr Pathol Paediatr Pathol Soc. 2010;13(3):209–17. PubMed Epub 2010/01/09. eng.
CrossRef
123.
Divyambika CV, Sathasivasubramanian S, Krithika CL, Malathi N, Prathiba D. Pediatric oral leiomyosarcoma: rare case report. J Cancer Res Ther. 2012;8(2):282–5. PubMed Epub 2012/07/31. eng.
PubMedCrossRef
124.
Sethi A, Mrig S, Sethi D, Mandal AK, Agarwal AK. Parotid gland leiomyosarcoma in a child: an extremely unusual neoplasm. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102(1):82–4. PubMed Epub 2006/07/13. eng.
PubMedCrossRef
125.
Wang WX, Gaurav D, Wen L, Ye MF, Sun QR, Liu WJ, et al. Pediatric esophageal leiomyosarcoma: a case report. J Pediatr Surg. 2011;46(8):1646–50. PubMed Epub 2011/08/17. eng.
PubMedCrossRef
126.
Dhall D, Al-Ahmadie HA, Dhall G, Shen-Schwarz S, Tickoo SK. Pediatric renal cell carcinoma with oncocytoid features occurring in a child after chemotherapy for cardiac leiomyosarcoma. Urology. 2007;70(1):178.e13–5. PubMed Epub 2007/07/28. eng.
CrossRef
127.
Gehrmann J, Kehl HG, Diallo R, Debus V, Vogt J. Cardiac leiomyosarcoma of the right atrium in a teenager: unusual manifestation with a lifetime history of atrial ectopic tachycardia. Pacing Clin Electrophysiol PACE. 2001;24(7):1161–4. PubMed Epub 2001/07/31. eng.
PubMedCrossRef
128.
Lai D-S, Lue K-H, Su J-M, Chang H. Primary bronchopulmonary leiomyosarcoma of the left main bronchus in a child presenting with wheezing and atelectasis of the left lung. Pediatr Pulmonol. 2002;33(4):318–21.
PubMedCrossRef
129.
Ferrari A, Collini P, Casanova M, Meazza C, Podda M, Mazza EA. Response to chemotherapy in a child with primary bronchopulmonary leiomyosarcoma. Med Pediatr Oncol. 2002;39(1):55–7.
PubMedCrossRef
130.
Suzuki K, Urushihara N, Fukumoto K, Watanabe K, Wada N, Takaba E. A case of Epstein-Barr virus-associated pulmonary leiomyosarcoma arising five yr after a pediatric renal transplant. Pediatr Transplant. 2011;15(7):145–8. PubMed Epub 2010/05/12. eng.
CrossRef
131.
Zhang H, Jensen MH, Farnell MB, Smyrk TC, Zhang L. Primary leiomyosarcoma of the pancreas: study of 9 cases and review of literature. Am J Surg Pathol. 2010;34(12):1849–56. PubMed Epub 2010/11/26. eng.
PubMedCrossRef
132.
Iwasaki M, Kitaguchi K, Kobayashi H. Mesenteric leiomyosarcoma in a 13-year-old boy. J Pediatr Surg. 2010;45(9):1893–5. PubMed Epub 2010/09/21. eng.
PubMedCrossRef
133.
McLoughlin LC, Nord KS, Joshi VV, DiCarlo FJ, Kane MJ. Disseminated leiomyosarcoma in a child with acquired immune deficiency syndrome. Cancer. 1991;67(10):2618–21. PubMed Epub 1991/05/15. eng.
PubMedCrossRef
134.
McClain KL, Leach CT, Jenson HB, Joshi VV, Pollock BH, Parmley RT, et al. Association of Epstein-Barr virus with leiomyosarcomas in children with AIDS. N Engl J Med. 1995;332(1):12–8. PubMed Epub 1995/01/05. eng.
PubMedCrossRef
135.
Shen SC, Yunis EJ. Leiomyosarcoma developing in a child during remission of leukemia. J Pediatr. 1976;89(5):780–2. PubMed Epub 1976/11/01. eng.
PubMedCrossRef
136.
Bisogno G, Spiller M, Scarzello G, Cecchetto G, Mascarin M, Indolfi P, et al. Secondary leiomyosarcomas: a report of 4 cases. Pediatr Hematol Oncol. 2005;22(2):181–7. PubMed Epub 2005/04/05. eng.
PubMedCrossRef
137.
Wong FL, Boice Jr JD, Abramson DH, Tarone RE, Kleinerman RA, Stovall M, et al. Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA. 1997;278(15):1262–7. PubMed Epub 1997/10/23 22:28. eng.
PubMedCrossRef
138.
Venkatraman L, Goepel JR, Steele K, Dobbs SP, Lyness RW, McCluggage WG. Soft tissue, pelvic, and urinary bladder leiomyosarcoma as second neoplasm following hereditary retinoblastoma. J Clin Pathol. 2003;56(3):233–6. PubMed Pubmed Central PMCID: 1769895. Epub 2003/03/01. eng.
PubMedPubMedCentralCrossRef
139.
Parekh DJ, Jung C, O’Conner J, Dutta S, Smith Jr ER. Leiomyosarcoma in urinary bladder after cyclophosphamide therapy for retinoblastoma and review of bladder sarcomas. Urology. 2002;60(1):164. PubMed Epub 2002/07/09. eng.
PubMedCrossRef
140.
Kawamura J, Sakurai M, Tsukamoto K, Tochigi H. Leiomyosarcoma of the bladder eighteen years after cyclophosphamide therapy for retinoblastoma. Urol Int. 1993;51(1):49–53. PubMed Epub 1993/01/01. eng.
PubMedCrossRef
141.
Hwang ES, Gerald W, Wollner N, Meyers P, La Quaglia MP. Leiomyosarcoma in childhood and adolescence. Ann Surg Oncol. 1997;4(3):223–7. PubMed Epub 1997/04/01. eng.
PubMedCrossRef
142.
Ferrari A, Bisogno G, Casanova M, Meazza C, Cecchetto G, Mancini MA, et al. Childhood leiomyosarcoma: a report from the soft tissue sarcoma Italian Cooperative Group. Ann Oncol Off J Eur Soc Med Oncol/ESMO. 2001;12(8):1163–8. PubMed Epub 2001/10/05. eng.
CrossRef
143.
Alaggio R, Coffin CM, Weiss SW, Bridge JA, Issakov J, Oliveira AM, et al. Liposarcomas in young patients: a study of 82 cases occurring in patients younger than 22 years of age. Am J Surg Pathol. 2009;33(5):645–58. PubMed Epub 2009/02/06. eng.
PubMedCrossRef
144.
Huh WW, Yuen C, Munsell M, Hayes-Jordan A, Lazar AJ, Patel S, et al. Liposarcoma in children and young adults: a multi-institutional experience. Pediatr Blood Cancer. 2011;57(7):1142–6. PubMed Pubmed Central PMCID: 3134599. Epub 2011/03/12. eng.
PubMedPubMedCentralCrossRef
145.
Ferrari A, Bisogno G, Macaluso A, Casanova M, D’Angelo P, Pierani P, et al. Soft-tissue sarcomas in children and adolescents with neurofibromatosis type 1. Cancer. 2007;109(7):1406–12. PubMed Epub 2007/03/03. eng.
PubMedCrossRef
146.
Carli M, Ferrari A, Mattke A, Zanetti I, Casanova M, Bisogno G, et al. Pediatric malignant peripheral nerve sheath tumor: the Italian and German soft tissue sarcoma cooperative group. J Clin Oncol Off J Am Soc Clin Oncol. 2005;23(33):8422–30. PubMed Epub 2005/11/19. eng.
CrossRef
147.
Ward BA, Gutmann DH. Neurofibromatosis 1: from lab bench to clinic. Pediatr Neurol. 2005;32(4):221–8. PubMed Epub 2005/03/31. eng.
PubMedCrossRef
148.
Gutmann DH, Aylsworth A, Carey JC, Korf B, Marks J, Pyeritz RE, et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA. 1997;278(1):51–7. PubMed Epub 1997/07/02. eng.
PubMedCrossRef
149.
Ferrari A, Bisogno G, Carli M. Management of childhood malignant peripheral nerve sheath tumor. Paediatr Drugs. 2007;9(4):239–48. PubMed Epub 2007/08/21. eng.
PubMedCrossRef
150.
Friedman JM. Review article : neurofibromatosis 1: clinical manifestations and diagnostic criteria. J Child Neurol. 2002;17(8):548–54.
PubMedCrossRef
151.
Anghileri M, Miceli R, Fiore M, Mariani L, Ferrari A, Mussi C, et al. Malignant peripheral nerve sheath tumors: prognostic factors and survival in a series of patients treated at a single institution. Cancer. 2006;107(5):1065–74. PubMed Epub 2006/08/02. eng.
PubMedCrossRef
152.
Mancuso T, Mezzelani A, Riva C, Fabbri A, Dal Bo L, Sampietro G, et al. Analysis of SYT-SSX fusion transcripts and bcl-2 expression and phosphorylation status in synovial sarcoma. Lab Invest J Tech Methods Pathol. 2000;80(6):805–13. PubMed Epub 2000/07/06. eng.
CrossRef
153.
Mezzelani A, Mariani L, Tamborini E, Agus V, Riva C, Lo Vullo S, et al. SYT-SSX fusion genes and prognosis in synovial sarcoma. Br J Cancer. 2001;85(10):1535–9. PubMed Pubmed Central PMCID: 2363950. Epub 2001/11/27. eng.
PubMedPubMedCentralCrossRef
154.
Mazeron JJ, Suit HD. Lymph nodes as sites of metastases from sarcomas of soft tissue. Cancer. 1987;60(8):1800–8. PubMed Epub 1987/10/15. eng.
PubMedCrossRef
155.
Tunn PU, Andreou D, Illing H, Fleige B, Dresel S, Schlag PM. Sentinel node biopsy in synovial sarcoma. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. 2008;34(6):704–7. PubMed Epub 2007/09/18. eng.
156.
Maduekwe UN, Hornicek FJ, Springfield DS, Raskin KA, Harmon DC, Choy E, et al. Role of sentinel lymph node biopsy in the staging of synovial, epithelioid, and clear cell sarcomas. Ann Surg Oncol. 2009;16(5):1356–63. PubMed Epub 2009/03/05. eng.
PubMedCrossRef
157.
O’Sullivan B, Davis AM, Turcotte R, Bell R, Catton C, Chabot P, et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet. 2002;359(9325):2235–41. PubMed Epub 2002/07/10. eng.
PubMedCrossRef
158.
Brecht IB, Ferrari A, Int-Veen C, Schuck A, Mattke AC, Casanova M, et al. Grossly-resected synovial sarcoma treated by the German and Italian Pediatric Soft Tissue Sarcoma Cooperative Groups: discussion on the role of adjuvant therapies. Pediatr Blood Cancer. 2006;46(1):11–7. PubMed Epub 2005/11/18. eng.
PubMedCrossRef
159.
Ferrari A, Miceli R, Rey A, Oberlin O, Orbach D, Brennan B, et al. Non-metastatic unresected paediatric non-rhabdomyosarcoma soft tissue sarcomas: results of a pooled analysis from United States and European groups. Eur J Cancer. 2011;47(5):724–31. PubMed Pubmed Central PMCID: 3539303. Epub 2010/12/15. eng.
PubMedPubMedCentralCrossRef
160.
Okcu MF, Munsell M, Treuner J, Mattke A, Pappo A, Cain A, et al. Synovial sarcoma of childhood and adolescence: a multicenter, multivariate analysis of outcome. J Clin Oncol Off J Am Soc Clin Oncol. 2003;21(8):1602–11. PubMed Epub 2003/04/17. eng.
CrossRef
161.
Orbach D, Mc Dowell H, Rey A, Bouvet N, Kelsey A, Stevens MC. Sparing strategy does not compromise prognosis in pediatric localized synovial sarcoma: experience of the International Society of Pediatric Oncology, Malignant Mesenchymal Tumors (SIOP-MMT) Working Group. Pediatr Blood Cancer. 2011;57(7):1130–6. PubMed Epub 2011/04/16. eng.
PubMedCrossRef
162.
Brennan B, Stevens M, Kelsey A, Stiller CA. Synovial sarcoma in childhood and adolescence: a retrospective series of 77 patients registered by the Children’s Cancer and Leukaemia Group between 1991 and 2006. Pediatr Blood Cancer. 2010;55(1):85–90. PubMed Epub 2010/03/10. eng.
PubMed
163.
Ladenstein R, Treuner J, Koscielniak E, d’Oleire F, Keim M, Gadner H, et al. Synovial sarcoma of childhood and adolescence. Report of the German CWS-81 study. Cancer. 1993;71(11):3647–55. PubMed Epub 1993/06/01. eng.
PubMedCrossRef
164.
Ferrari A, Bisogno G, Alaggio R, Cecchetto G, Collini P, Rosolen A, et al. Synovial sarcoma of children and adolescents: the prognostic role of axial sites. Eur J Cancer. 2008;44(9):1202–9. PubMed Epub 2008/04/29. eng.
PubMedCrossRef
165.
Ferrari A, De Salvo GL, Oberlin O, Casanova M, De Paoli A, Rey A, et al. Synovial sarcoma in children and adolescents: a critical reappraisal of staging investigations in relation to the rate of metastatic involvement at diagnosis. Eur J Cancer. 2012;48(9):1370–5. PubMed Epub 2012/02/11. eng.
PubMedCrossRef
166.
Perez EA, Kassira N, Cheung MC, Koniaris LG, Neville HL, Sola JE. Rhabdomyosarcoma in children: a SEER population based study. J Surg Res. 2011;170(2):e243–51. PubMed.
PubMedCrossRef
167.
Ruymann FB, Maddux HR, Ragab A, Soule EH, Palmer N, Beltangady M, et al. Congenital anomalies associated with rhabdomyosarcoma: an autopsy study of 115 cases. A report from the Intergroup Rhabdomyosarcoma Study Committee (representing the Children’s Cancer Study Group, the Pediatric Oncology Group, the United Kingdom Children’s Cancer Study Group, and the Pediatric Intergroup Statistical Center). Med Pediatr Oncol. 1988;16(1):33–9. PubMed.
PubMedCrossRef
168.
Sung L, Anderson JR, Arndt C, Raney RB, Meyer WH, Pappo AS. Neurofibromatosis in children with Rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma study IV. J Pediatr. 2004;144(5):666–8. PubMed.
PubMedCrossRef
169.
Miller RW, Rubinstein JH. Tumors in Rubinstein-Taybi syndrome. Am J Med Genet. 1995;56(1):112–5. PubMed.
PubMedCrossRef
170.
Hennekam RC, Huber J, Variend D. Bartsocas-Papas syndrome with internal anomalies: evidence for a more generalized epithelial defect or new syndrome? Am J Med Genet. 1994;53(2):102–7. PubMed Epub 1994/11/01. eng.
PubMedCrossRef
171.
Malkin D, Friend SH. Correction: a Li-Fraumeni syndrome p53 mutation. Science. 1993;259(5097):878. PubMed.
PubMedCrossRef
172.
Varley JM, McGown G, Thorncroft M, Santibanez-Koref MF, Kelsey AM, Tricker KJ, et al. Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families. Cancer Res. 1997;57(15):3245–52. PubMed.
PubMed
173.
Li FP, Fraumeni Jr JF. Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med. 1969;71(4):747–52. PubMed.
PubMedCrossRef
174.
Grufferman S, Schwartz AG, Ruymann FB, Maurer HM. Parents’ use of cocaine and marijuana and increased risk of rhabdomyosarcoma in their children. Cancer Causes Control CCC. 1993;4(3):217–24. PubMed.
PubMed
175.
Grufferman S, Wang HH, DeLong ER, Kimm SY, Delzell ES, Falletta JM. Environmental factors in the etiology of rhabdomyosarcoma in childhood. J Natl Cancer Inst. 1982;68(1):107–13. PubMed.
PubMed
176.
Ognjanovic S, Carozza SE, Chow EJ, Fox EE, Horel S, McLaughlin CC, et al. Birth characteristics and the risk of childhood rhabdomyosarcoma based on histological subtype. Br J Cancer. 2010;102(1):227–31. PubMed Pubmed Central PMCID: 2813761.
PubMedPubMedCentralCrossRef
177.
Wexler LH, Helman LJ. Pediatric soft tissue sarcomas. CA Cancer J Clin. 1994;44(4):211–47. PubMed.
PubMedCrossRef
178.
Andrassy RJ, Wiener ES, Raney RB, Hays DM, Arndt CA, Lobe TE, et al. Progress in the surgical management of vaginal rhabdomyosarcoma: a 25-year review from the Intergroup Rhabdomyosarcoma Study Group. J Pediatr Surg. 1999;34(5):731–4; discussion 4–5. PubMed Epub 1999/06/08. eng.
PubMedCrossRef
179.
Parham DM, Webber B, Holt H, Williams WK, Maurer H. Immunohistochemical study of childhood rhabdomyosarcomas and related neoplasms. Results of an Intergroup Rhabdomyosarcoma study project. Cancer. 1991;67(12):3072–80. PubMed.
PubMedCrossRef
180.
Dias P, Parham DM, Shapiro DN, Webber BL, Houghton PJ. Myogenic regulatory protein (MyoD1) expression in childhood solid tumors: diagnostic utility in rhabdomyosarcoma. Am J Pathol. 1990;137(6):1283–91. PubMed Pubmed Central PMCID: 1877713.
PubMedPubMedCentral
181.
Newton Jr WA, Gehan EA, Webber BL, Marsden HB, van Unnik AJ, Hamoudi AB, et al. Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification – an Intergroup Rhabdomyosarcoma Study. Cancer. 1995;76(6):1073–85. PubMed.
PubMedCrossRef
182.
Newton WA, et al. Rhabdomyosarcoma and related tumors in children and adolescents. In: Maurer HMRF, Pochedly C, editors. Pathology of rhabdomyosarcoma and related tumors. Boca Raton: CRC Press; 1991.
183.
Asmar L, Gehan EA, Newton WA, Webber BL, Marsden HB, van Unnik AJ, et al. Agreement among and within groups of pathologists in the classification of rhabdomyosarcoma and related childhood sarcomas. Report of an international study of four pathology classifications. Cancer. 1994;74(9):2579–88. PubMed.
PubMedCrossRef
184.
Newton Jr WA, Soule EH, Hamoudi AB, Reiman HM, Shimada H, Beltangady M, et al. Histopathology of childhood sarcomas, Intergroup Rhabdomyosarcoma Studies I and II: clinicopathologic correlation. J Clin Oncol Off J Am Soc Clin Oncol. 1988;6(1):67–75. PubMed.
185.
Kodet R, Newton Jr WA, Hamoudi AB, Asmar L, Jacobs DL, Maurer HM. Childhood rhabdomyosarcoma with anaplastic (pleomorphic) features. A report of the Intergroup Rhabdomyosarcoma Study. Am J Surg Pathol. 1993;17(5):443–53. PubMed.
PubMedCrossRef
186.
Bridge JA, Liu J, Weibolt V, Baker KS, Perry D, Kruger R, et al. Novel genomic imbalances in embryonal rhabdomyosarcoma revealed by comparative genomic hybridization and fluorescence in situ hybridization: an intergroup rhabdomyosarcoma study. Genes Chromosomes Cancer. 2000;27(4):337–44. PubMed.
PubMedCrossRef
187.
Turc-Carel C, Lizard-Nacol S, Justrabo E, Favrot M, Philip T, Tabone E. Consistent chromosomal translocation in alveolar rhabdomyosarcoma. Cancer Genet Cytogenet. 1986;19(3–4):361–2. PubMed.
PubMedCrossRef
188.
Barr FG, Smith LM, Lynch JC, Strzelecki D, Parham DM, Qualman SJ, et al. Examination of gene fusion status in archival samples of alveolar rhabdomyosarcoma entered on the Intergroup Rhabdomyosarcoma Study-III trial: a report from the Children’s Oncology Group. J Mol Diagn JMD. 2006;8(2):202–8. PubMed Pubmed Central PMCID: 1867584.
PubMedCrossRef
189.
Sorensen PH, Lynch JC, Qualman SJ, Tirabosco R, Lim JF, Maurer HM, et al. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children’s oncology group. J Clin Oncol Off J Am Soc Clin Oncol. 2002;20(11):2672–9. PubMed Epub 2002/06/01. eng.
CrossRef
190.
Dagher R, Helman L. Rhabdomyosarcoma: an overview. Oncologist. 1999;4(1):34–44. PubMed.
PubMed
191.
Li M, Squire JA, Weksberg R. Molecular genetics of Beckwith-Wiedemann syndrome. Curr Opin Pediatr. 1997;9(6):623–9. PubMed.
PubMedCrossRef
192.
Morison IM, Reeve AE. Insulin-like growth factor 2 and overgrowth: molecular biology and clinical implications. Mol Med Today. 1998;4(3):110–5. PubMed.
PubMedCrossRef
193.
Williamson D, Missiaglia E, de Reynies A, Pierron G, Thuille B, Palenzuela G, et al. Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma. J Clin Oncol Off J Am Soc Clin Oncol. 2010;28(13):2151–8. PubMed.
CrossRef
194.
Davicioni E, Anderson JR, Buckley JD, Meyer WH, Triche TJ. Gene expression profiling for survival prediction in pediatric rhabdomyosarcomas: a report from the children’s oncology group. J Clin Oncol Off J Am Soc Clin Oncol. 2010;28(7):1240–6. PubMed Pubmed Central PMCID: 3040045.
CrossRef
195.
Lobe TE, Wiener ES, Hays DM, Lawrence WH, Andrassy RJ, Johnston J, et al. Neonatal rhabdomyosarcoma: the IRS experience. J Pediatr Surg. 1994;29(8):1167–70. PubMed.
PubMedCrossRef
196.
Dasgupta R, Rodeberg DA. Update on rhabdomyosarcoma. Semin Pediatr Surg. 2012;21(1):68–78. PubMed.
PubMedCrossRef
197.
Yokouchi M, Terahara M, Nagano S, Arishima Y, Zemmyo M, Yoshioka T, et al. Clinical implications of determination of safe surgical margins by using a combination of CT and 18FDG-positron emission tomography in soft tissue sarcoma. BMC Musculoskelet Disord. 2011;12:166. PubMed Pubmed Central PMCID: 3224246.
PubMedPubMedCentralCrossRef
198.
O’Sullivan F, Wolsztynski E, O’Sullivan J, Richards T, Conrad EU, Eary JF. A statistical modeling approach to the analysis of spatial patterns of FDG-PET uptake in human sarcoma. IEEE Trans Med Imaging. 2011;30(12):2059–71. PubMed.
PubMedPubMedCentralCrossRef
199.
Kumar R, Shandal V, Shamim SA, Halanaik D, Malhotra A. Clinical applications of PET and PET/CT in pediatric malignancies. Expert Rev Anticancer Ther. 2010;10(5):755–68. PubMed Epub 2010/05/18. eng.
PubMedCrossRef
200.
Mody RJ, Bui C, Hutchinson RJ, Yanik GA, Castle VP, Frey KA, et al. FDG PET imaging of childhood sarcomas. Pediatr Blood Cancer. 2010;54(2):222–7. PubMed Pubmed Central PMCID: PMC2794959. Epub 2009/11/06. eng.
PubMedPubMedCentral
201.
Tateishi U, Hosono A, Makimoto A, Nakamoto Y, Kaneta T, Fukuda H, et al. Comparative study of FDG PET/CT and conventional imaging in the staging of rhabdomyosarcoma. Ann Nucl Med. 2009;23(2):155–61. PubMed Epub 2009/02/20. eng.
PubMedCrossRef
202.
Lawrence Jr W, Anderson JR, Gehan EA, Pretreatment MH, TNM. staging of childhood rhabdomyosarcoma: a report of the Intergroup Rhabdomyosarcoma Study Group. Children’s Cancer Study Group. Pediatric Oncology Group. Cancer. 1997;80(6):1165–70. PubMed.
PubMedCrossRef
203.
Lawrence Jr W, Gehan EA, Hays DM, Beltangady M, Maurer HM. Prognostic significance of staging factors of the UICC staging system in childhood rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study (IRS-II). J Clin Oncol Off J Am Soc Clin Oncol. 1987;5(1):46–54. PubMed.
204.
Ruymann FB. Rhabdomyosarcoma in children and adolescents. A review. Hematol Oncol Clin North Am. 1987;1(4):621–54. PubMed.
PubMed
205.
Stobbe GD, Dargeon HW. Embryonal rhabdomyosarcoma of the head and neck in children and adolescents. Cancer. 1950;3(5):826–36. PubMed.
PubMedCrossRef
206.
Pinkel D, Pickren J. Rhabdomyosarcoma in children. JAMA. 1961;175:293–8. PubMed.
PubMedCrossRef
207.
Crew AJ, Clark J, Fisher C, Gill S, Grimer R, Chand A, et al. Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma. EMBO J. 1995;14(10):2333–40. PubMed Pubmed Central PMCID: PMC398342. Epub 1995/05/15. eng.
PubMedPubMedCentral
208.
Malempati S, Hawkins DS. Rhabdomyosarcoma: review of the Children’s Oncology Group (COG) Soft-Tissue Sarcoma Committee experience and rationale for current COG studies. Pediatr Blood Cancer. 2012;59(1):5–10. PubMed.
PubMedPubMedCentralCrossRef
209.
Hays DM, Lawrence Jr W, Wharam M, Newton Jr W, Ruymann FB, Beltangady M, et al. Primary reexcision for patients with ‘microscopic residual’ tumor following initial excision of sarcomas of trunk and extremity sites. J Pediatr Surg. 1989;24(1):5–10. PubMed Epub 1989/01/01. eng.
PubMedCrossRef
210.
Meza JL, Anderson J, Pappo AS, Meyer WH, Children’s Oncology Group. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children’s Oncology Group. J Clin Oncol Off J Am Soc Clin Oncol. 2006;24(24):3844–51. PubMed.
CrossRef
211.
Rodeberg DA, Anderson JR, Arndt CA, Ferrer FA, Raney RB, Jenney ME, et al. Comparison of outcomes based on treatment algorithms for rhabdomyosarcoma of the bladder/prostate: combined results from the Children’s Oncology Group, German Cooperative Soft Tissue Sarcoma Study, Italian Cooperative Group, and International Society of Pediatric Oncology Malignant Mesenchymal Tumors Committee. Int J Cancer Journal International du Cancer. 2011;128(5):1232–9. PubMed.
PubMedCrossRef
212.
Wiener ES, Anderson JR, Ojimba JI, Lobe TE, Paidas C, Andrassy RJ, et al. Controversies in the management of paratesticular rhabdomyosarcoma: is staging retroperitoneal lymph node dissection necessary for adolescents with resected paratesticular rhabdomyosarcoma? Semin Pediatr Surg. 2001;10(3):146–52. PubMed.
PubMedCrossRef
213.
Wiener ES, Lawrence W, Hays D, Lobe TE, Andrassy R, Donaldson S, et al. Retroperitoneal node biopsy in paratesticular rhabdomyosarcoma. J Pediatr Surg. 1994;29(2):171–7; discussion 178. PubMed.
PubMedCrossRef
214.
Leaphart C, Rodeberg D. Pediatric surgical oncology: management of rhabdomyosarcoma. Surg Oncol. 2007;16(3):173–85. PubMed Epub 2007/08/11. eng.
PubMedCrossRef
215.
Neville HL, Andrassy RJ, Lobe TE, Bagwell CE, Anderson JR, Womer RB, et al. Preoperative staging, prognostic factors, and outcome for extremity rhabdomyosarcoma: a preliminary report from the Intergroup Rhabdomyosarcoma Study IV (1991–1997). J Pediatr Surg. 2000;35(2):317–21. PubMed.
PubMedCrossRef
216.
Hays DM, Raney RB, Crist WM, Lawrence Jr WW, Ragab A, Wharam MD, et al. Secondary surgical procedures to evaluate primary tumor status in patients with chemotherapy-responsive stage III and IV sarcomas: a report from the Intergroup Rhabdomyosarcoma Study. J Pediatr Surg. 1990;25(10):1100–5. PubMed.
PubMedCrossRef
217.
Godzinski J, Flamant F, Rey A, Praquin MT, Martelli H. Value of postchemotherapy bioptical verification of complete clinical remission in previously incompletely resected (stage I and II pT3) malignant mesenchymal tumors in children: International Society of Pediatric Oncology 1984 Malignant Mesenchymal Tumors Study. Med Pediatr Oncol. 1994;22(1):22–6. PubMed.
PubMedCrossRef
218.
Wiener ES. Rhabdomyosarcoma: new dimensions in management. Semin Pediatr Surg. 1993;2(1):47–58. PubMed.
PubMed
219.
Wiener ES, et al. Rhabdomyosarcoma in extremity and trunk sites. In: Maurer HMRF, Pochedly C, editors. Rhabdomyosarcoma and related tumors in children and adolescents. Boca Raton: CRC Press; 1991.
220.
Weiner ES, et al. Second look operations in children in group III and IV rhabdomyosarcoma (RMS. Med Pediatr Oncol. 1990;18:408.
221.
Wiener E, et al. Complete response or not complete response? Second look operations are the answer in children with rhabdomyosarcoma. Proc Am Soc. Clin Oncol. 1991;10:316.
222.
Raney B, Stoner J, Anderson J, Andrassy R, Arndt C, Brown K, et al. Impact of tumor viability at second-look procedures performed before completing treatment on the Intergroup Rhabdomyosarcoma Study Group protocol IRS-IV, 1991–1997: a report from the children’s oncology group. J Pediatr Surg. 2010;45(11):2160–8. PubMed Pubmed Central PMCID: 3128803.
PubMedPubMedCentralCrossRef
223.
Pappo AS, Anderson JR, Crist WM, Wharam MD, Breitfeld PP, Hawkins D, et al. Survival after relapse in children and adolescents with rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study Group. J Clin Oncol Off J Am Soc Clin Oncol. 1999;17(11):3487–93. PubMed.
224.
Hayes-Jordan A, Doherty DK, West SD, Raney RB, Blakely ML, Cox Jr CS, et al. Outcome after surgical resection of recurrent rhabdomyosarcoma. J Pediatr Surg. 2006;41(4):633–8; discussion 633−8. PubMed.
PubMedCrossRef
225.
Cofer BR, et al. Rhabdomyosarcoma. In: Richard J Andrassy, editor. Pediatric surgical oncology, Saunders, Philadelphia; 1998.
226.
Breneman JC, Lyden E, Pappo AS, Link MP, Anderson JR, Parham DM, et al. Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma – a report from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol Off J Am Soc Clin Oncol. 2003;21(1):78–84. PubMed Epub 2002/12/31. eng.
CrossRef
227.
Dantonello TM, Winkler P, Boelling T, Friedel G, Schmid I, Mattke AC, et al. Embryonal rhabdomyosarcoma with metastases confined to the lungs: report from the CWS Study Group. Pediatr Blood Cancer. 2011;56(5):725–32. PubMed.
PubMedCrossRef
228.
Raney RB, Walterhouse DO, Meza JL, Andrassy RJ, Breneman JC, Crist WM, et al. Results of the Intergroup Rhabdomyosarcoma Study Group D9602 protocol, using vincristine and dactinomycin with or without cyclophosphamide and radiation therapy, for newly diagnosed patients with low-risk embryonal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children’s Oncology Group. J Clin Oncol Off J Am Soc Clin Oncol. 2011;29(10):1312–8. PubMed Pubmed Central PMCID: PMC3083999. Epub 2011/03/02. eng.
CrossRef
229.
Crist WM, Anderson JR, Meza JL, Fryer C, Raney RB, Ruymann FB, et al. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol Off J Am Soc Clin Oncol. 2001;19(12):3091–102. PubMed.
230.
Walterhouse DO, Lyden ER, Breitfeld PP, Qualman SJ, Wharam MD, Meyer WH. Efficacy of topotecan and cyclophosphamide given in a phase II window trial in children with newly diagnosed metastatic rhabdomyosarcoma: a Children’s Oncology Group study. J Clin Oncol Off J Am Soc Clin Oncol. 2004;22(8):1398–403. PubMed.
CrossRef
231.
Saylors 3rd RL, Stine KC, Sullivan J, Kepner JL, Wall DA, Bernstein ML, et al. Cyclophosphamide plus topotecan in children with recurrent or refractory solid tumors: a Pediatric Oncology Group phase II study. J Clin Oncol Off J Am Soc Clin Oncol. 2001;19(15):3463–9. PubMed.
232.
Baker KS, Anderson JR, Link MP, Grier HE, Qualman SJ, Maurer HM, et al. Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol Off J Am Soc Clin Oncol. 2000;18(12):2427–34. PubMed Epub 2000/06/16. eng.
233.
Spunt SL, Smith LM, Ruymann FB, Qualman SJ, Donaldson SS, Rodeberg DA, et al. Cyclophosphamide dose intensification during induction therapy for intermediate-risk pediatric rhabdomyosarcoma is feasible but does not improve outcome: a report from the soft tissue sarcoma committee of the children’s oncology group. Clin Cancer Res Off J Am Assoc Cancer Res. 2004;10(18 Pt 1):6072–9. PubMed.
CrossRef
234.
Breitfeld PP, Lyden E, Raney RB, Teot LA, Wharam M, Lobe T, et al. Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: a report from the Intergroup Rhabdomyosarcoma Study Group. J Pediatr Hematol Oncol. 2001;23(4):225–33. PubMed.
PubMedCrossRef
235.
Sandler E, Lyden E, Ruymann F, Maurer H, Wharam M, Parham D, et al. Efficacy of ifosfamide and doxorubicin given as a phase II “window” in children with newly diagnosed metastatic rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study Group. Med Pediatr Oncol. 2001;37(5):442–8. PubMed.
PubMedCrossRef
236.
Pappo AS, Lyden E, Breitfeld P, Donaldson SS, Wiener E, Parham D, et al. Two consecutive phase II window trials of irinotecan alone or in combination with vincristine for the treatment of metastatic rhabdomyosarcoma: the Children’s Oncology Group. J Clin Oncol Off J Am Soc Clin Oncol. 2007;25(4):362–9. PubMed.
CrossRef
237.
Bergeron C, Thiesse P, Rey A, Orbach D, Boutard P, Thomas C, et al. Revisiting the role of doxorubicin in the treatment of rhabdomyosarcoma: an up-front window study in newly diagnosed children with high-risk metastatic disease. Eur J Cancer. 2008;44(3):427–31. PubMed.
PubMedCrossRef
238.
McDowell HP, Foot AB, Ellershaw C, Machin D, Giraud C, Bergeron C. Outcomes in paediatric metastatic rhabdomyosarcoma: results of The International Society of Paediatric Oncology (SIOP) study MMT-98. Eur J Cancer. 2010;46(9):1588–95. PubMed.
PubMedCrossRef
239.
Pappo AS, Lyden E, Breneman J, Wiener E, Teot L, Meza J, et al. Up-front window trial of topotecan in previously untreated children and adolescents with metastatic rhabdomyosarcoma: an intergroup rhabdomyosarcoma study. J Clin Oncol Off J Am Soc Clin Oncol. 2001;19(1):213–9. PubMed Epub 2001/01/03. eng.
240.
Peinemann F, Kroger N, Bartel C, Grouven U, Pittler M, Erttmann R, et al. High-dose chemotherapy followed by autologous stem cell transplantation for metastatic rhabdomyosarcoma – a systematic review. PLoS One. 2011;6(2):e17127. PubMed Pubmed Central PMCID: 3044147.
PubMedPubMedCentralCrossRef
241.
Admiraal R, van der Paardt M, Kobes J, Kremer LC, Bisogno G, Merks JH. High-dose chemotherapy for children and young adults with stage IV rhabdomyosarcoma. Cochrane Database Syst Rev. 2010;(12):CD006669. PubMed.
242.
Million L, Anderson J, Breneman J, Hawkins DS, Laurie F, Michalski J, et al. Influence of noncompliance with radiation therapy protocol guidelines and operative bed recurrences for children with rhabdomyosarcoma and microscopic residual disease: a report from the Children’s Oncology Group. Int J Radiat Oncol Biol Phys. 2011;80(2):333–8. PubMed.
PubMedPubMedCentralCrossRef
243.
Donaldson SS, Meza J, Breneman JC, Crist WM, Laurie F, Qualman SJ, et al. Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma – a report from the IRSG. Int J Radiat Oncol Biol Phys. 2001;51(3):718–28. PubMed.
PubMedCrossRef
244.
Mandell L, Ghavimi F, Peretz T, LaQuaglia M, Exelby P. Radiocurability of microscopic disease in childhood rhabdomyosarcoma with radiation doses less than 4,000 cGy. J Clin Oncol Off J Am Soc Clin Oncol. 1990;8(9):1536–42. PubMed.
245.
Wolden SL, Anderson JR, Crist WM, Breneman JC, Wharam Jr MD, Wiener ES, et al. Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Studies I to III. J Clin Oncol Off J Am Soc Clin Oncol. 1999;17(11):3468–75. PubMed.
246.
Puri DR, Wexler LH, Meyers PA, La Quaglia MP, Healey JH, Wolden SL. The challenging role of radiation therapy for very young children with rhabdomyosarcoma. Int J Radiat Oncol Biol Phys. 2006;65(4):1177–84. PubMed.
PubMedCrossRef
247.
Paulino AC, Simon JH, Zhen W, Wen BC. Long-term effects in children treated with radiotherapy for head and neck rhabdomyosarcoma. Int J Radiat Oncol Biol Phys. 2000;48(5):1489–95. PubMed.
PubMedCrossRef
248.
Fiorillo A, Migliorati R, Vassallo P, Canale G, Tranfa F, Fariello I, et al. Radiation late effects in children treated for orbital rhabdomyosarcoma. Radiother Oncol J Eur Soc Ther Radiol Oncol. 1999;53(2):143–8. PubMed.
CrossRef
249.
Raney Jr B, Heyn R, Hays DM, Tefft M, Newton Jr WA, Wharam M, et al. Sequelae of treatment in 109 patients followed for 5 to 15 years after diagnosis of sarcoma of the bladder and prostate. A report from the Intergroup Rhabdomyosarcoma Study Committee. Cancer. 1993;71(7):2387–94. PubMed.
PubMedCrossRef
250.
Paulino AC. Late effects of radiotherapy for pediatric extremity sarcomas. Int J Radiat Oncol Biol Phys. 2004;60(1):265–74. PubMed.
PubMedCrossRef
251.
Heyn R, Haeberlen V, Newton WA, Ragab AH, Raney RB, Tefft M, et al. Second malignant neoplasms in children treated for rhabdomyosarcoma. Intergroup Rhabdomyosarcoma Study Committee. J Clin Oncol Off J Am Soc Clin Oncol. 1993;11(2):262–70. PubMed.
252.
Wolden SL, Dunkel IJ, Souweidane MM, Happersett L, Khakoo Y, Schupak K, et al. Patterns of failure using a conformal radiation therapy tumor bed boost for medulloblastoma. J Clin Oncol Off J Am Soc Clin Oncol. 2003;21(16):3079–83. PubMed.
CrossRef
253.
McDonald MW, Esiashvili N, George BA, Katzenstein HM, Olson TA, Rapkin LB, et al. Intensity-modulated radiotherapy with use of cone-down boost for pediatric head-and-neck rhabdomyosarcoma. Int J Radiat Oncol Biol Phys. 2008;72(3):884–91. PubMed.
PubMedCrossRef
254.
Hug EB, Adams J, Fitzek M, De Vries A, Munzenrider JE. Fractionated, three-dimensional, planning-assisted proton-radiation therapy for orbital rhabdomyosarcoma: a novel technique. Int J Radiat Oncol Biol Phys. 2000;47(4):979–84. PubMed.
PubMedCrossRef
255.
Yock T, Schneider R, Friedmann A, Adams J, Fullerton B, Tarbell N. Proton radiotherapy for orbital rhabdomyosarcoma: clinical outcome and a dosimetric comparison with photons. Int J Radiat Oncol Biol Phys. 2005;63(4):1161–8. PubMed.
PubMedCrossRef
256.
Nag S, Ciezki JP, Cormack R, Doggett S, DeWyngaert K, Edmundson GK, et al. Intraoperative planning and evaluation of permanent prostate brachytherapy: report of the American Brachytherapy Society. Int J Radiat Oncol Biol Phys. 2001;51(5):1422–30. PubMed.
PubMedCrossRef
257.
Magne N, Haie-Meder C. Brachytherapy for genital-tract rhabdomyosarcomas in girls: technical aspects, reports, and perspectives. Lancet Oncol. 2007;8(8):725–9. PubMed.
PubMedCrossRef
258.
Martelli H, Haie-Meder C, Branchereau S, Franchi-Abella S, Ghigna MR, Dumas I, et al. Conservative surgery plus brachytherapy treatment for boys with prostate and/or bladder neck rhabdomyosarcoma: a single team experience. J Pediatr Surg. 2009;44(1):190–6. PubMed.
PubMedCrossRef
259.
Magne N, Oberlin O, Martelli H, Gerbaulet A, Chassagne D, Haie-Meder C. Vulval and vaginal rhabdomyosarcoma in children: update and reappraisal of Institut Gustave Roussy brachytherapy experience. Int J Radiat Oncol Biol Phys. 2008;72(3):878–83. PubMed.
PubMedCrossRef
260.
Turner JH, Richmon JD. Head and neck rhabdomyosarcoma: a critical analysis of population-based incidence and survival data. Otolaryngol Head Neck Surg Off J Am Acad Otolaryngol Head Neck Surg. 2011;145(6):967–73. PubMed.
CrossRef
261.
Karcioglu ZA, Hadjistilianou D, Rozans M, DeFrancesco S. Orbital rhabdomyosarcoma. Cancer Control J Moffitt Cancer Center. 2004;11(5):328–33. PubMed.
262.
Shields CL, Shields JA, Cater J, Othmane I, Singh AD, Micaily B. Plaque radiotherapy for retinoblastoma: long-term tumor control and treatment complications in 208 tumors. Ophthalmology. 2001;108(11):2116–21. PubMed.
PubMedCrossRef
263.
Healy JN, Borg MF. Paediatric nasopharyngeal rhabdomyosarcoma: a case series and literature review. J Med Imaging Radiat Oncol. 2010;54(4):388–94. PubMed.
PubMedCrossRef
264.
Gradoni P, Giordano D, Oretti G, Fantoni M, Ferri T. The role of surgery in children with head and neck rhabdomyosarcoma and Ewing’s sarcoma. Surg Oncol. 2010;19(4):e103–9. PubMed.
PubMedCrossRef
265.
Raney RB, Meza J, Anderson JR, Fryer CJ, Donaldson SS, Breneman JC, et al. Treatment of children and adolescents with localized parameningeal sarcoma: experience of the Intergroup Rhabdomyosarcoma Study Group protocols IRS-II through -IV, 1978–1997. Med Pediatr Oncol. 2002;38(1):22–32. PubMed Epub 2002/02/09. eng.
PubMedCrossRef
266.
Zevallos JP, Jain K, Roberts D, Santillan AA, Huh W, Hanna EY, et al. Modern multimodality therapy for pediatric nonorbital parameningeal sarcomas. Head Neck. 2010;32(11):1501–5. PubMed.
PubMedCrossRef
267.
Weiss BD, Dasgupta R, Gelfand MJ, Laor T, Yin H, Breneman JC, et al. Use of sentinel node biopsy for staging parameningeal rhabdomyosarcoma. Pediatr Blood Cancer. 2011;57(3):520–3. PubMed.
PubMedCrossRef
268.
Bisogno G, De Rossi C, Gamboa Y, Sotti G, Ferrari A, Dallorso S, et al. Improved survival for children with parameningeal rhabdomyosarcoma: results from the AIEOP soft tissue sarcoma committee. Pediatr Blood Cancer. 2008;50(6):1154–8. PubMed.
PubMedCrossRef
269.
Raney RB, Anderson JR, Barr FG, Donaldson SS, Pappo AS, Qualman SJ, et al. Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V. J Pediatr Hematol Oncol. 2001;23(4):215–20. PubMed.
PubMedCrossRef
270.
Raney RB, Chintagumpala M, Anderson J, Pappo A, Qualman S, Wharam M, et al. Results of treatment of patients with superficial facial rhabdomyosarcomas on protocols of the Intergroup Rhabdomyosarcoma Study Group (IRSG), 1984–1997. Pediatr Blood Cancer. 2008;50(5):958–64. PubMed Pubmed Central PMCID: 3357210.
PubMedPubMedCentralCrossRef
271.
Combs SE, Behnisch W, Kulozik AE, Huber PE, Debus J, Schulz-Ertner D. Intensity Modulated Radiotherapy (IMRT) and Fractionated Stereotactic Radiotherapy (FSRT) for children with head-and-neck-rhabdomyosarcoma. BMC Cancer. 2007;7:177. PubMed Pubmed Central PMCID: 2077337.
PubMedPubMedCentralCrossRef
272.
Ferrer FA, Isakoff M, Koyle MA. Bladder/prostate rhabdomyosarcoma: past, present and future. J Urol. 2006;176(4 Pt 1):1283–91. PubMed.
PubMedCrossRef
273.
Arndt C, Rodeberg D, Breitfeld PP, Raney RB, Ullrich F, Donaldson S. Does bladder preservation (as a surgical principle) lead to retaining bladder function in bladder/prostate rhabdomyosarcoma? Results from intergroup rhabdomyosarcoma study iv. J Urol. 2004;171(6 Pt 1):2396–403. PubMed.
PubMedCrossRef
274.
Castellino SM, McLean TW. Pediatric genitourinary tumors. Curr Opin Oncol. 2007;19(3):248–53. PubMed.
PubMedCrossRef
275.
Hays DM, Lawrence Jr W, Crist WM, Wiener E, Raney Jr RB, Ragab A, et al. Partial cystectomy in the management of rhabdomyosarcoma of the bladder: a report from the Intergroup Rhabdomyosarcoma Study. J Pediatr Surg. 1990;25(7):719–23. PubMed.
PubMedCrossRef
276.
Hays DM, Raney RB, Wharam MD, Wiener E, Lobe TE, Andrassy RJ, et al. Children with vesical rhabdomyosarcoma (RMS) treated by partial cystectomy with neoadjuvant or adjuvant chemotherapy, with or without radiotherapy. A report from the Intergroup Rhabdomyosarcoma Study (IRS) Committee. J Pediatr Hematol Oncol. 1995;17(1):46–52. PubMed.
PubMedCrossRef
277.
Hays DM. Bladder/prostate rhabdomyosarcoma: results of the multi-institutional trials of the Intergroup Rhabdomyosarcoma Study. Semin Surg Onco 1993;9(6):520–3.
278.
Lobe TE, Wiener E, Andrassy RJ, Bagwell CE, Hays D, Crist WM, et al. The argument for conservative, delayed surgery in the management of prostatic rhabdomyosarcoma. J Pediatr Surg. 1996;31(8):1084–7. PubMed.
PubMedCrossRef
279.
Wu HY, Snyder 3rd HM, Womer RB. Genitourinary rhabdomyosarcoma: which treatment, how much, and when? J Pediatr Urol. 2009;5(6):501–6. PubMed Epub 2009/07/31. eng.
PubMedCrossRef
280.
Crist W, Gehan EA, Ragab AH, Dickman PS, Donaldson SS, Fryer C, et al. The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol Off J Am Soc Clin Oncol. 1995;13(3):610–30. PubMed.
281.
Hafez AT, Sarhan M, Sarhan O, El-Sherbiny MT, Ghoneim MA. Chemotherapy as monotherapy for treatment of non-metastatic bladder/prostate embryonal rhabdomyosarcoma in children: preliminary report. J Pediatr Urol. 2006;2(1):23–30. PubMed Epub 2008/10/25. eng.
PubMedCrossRef
282.
Soler R, Macedo Jr A, Bruschini H, Puty F, Caran E, Petrilli A, et al. Does the less aggressive multimodal approach of treating bladder-prostate rhabdomyosarcoma preserve bladder function? J Urol. 2005;174(6):2343–6. PubMed Epub 2005/11/11. eng.
PubMedCrossRef
283.
Raney B, Anderson J, Jenney M, Arndt C, Brecht I, Carli M, et al. Late effects in 164 patients with rhabdomyosarcoma of the bladder/prostate region: a report from the international workshop. J Urol. 2006;176(5):2190–4; discussion 2194–5. PubMed.
PubMedCrossRef
284.
Dall’Igna P, Bisogno G, Ferrari A, Treuner J, Carli M, Zanetti I, et al. Primary transcrotal excision for paratesticular rhabdomyosarcoma. Cancer. 2003;97(8):1981–4.
PubMedCrossRef
285.
Beverly Raney R, Sinclair L, Uri A, Schnaufer L, Cooper A, Littman P. Malignant ovarian tumors in children and adolescents. Cancer. 1987;59(6):1214–20.
CrossRef
286.
Lawrence Jr W, Hays DM, Heyn R, Tefft M, Crist W, Beltangady M, et al. Lymphatic metastases with childhood rhabdomyosarcoma. A report from the Intergroup Rhabdomyosarcoma Study. Cancer. 1987;60(4):910–5. PubMed Epub 1987/08/15. eng.
PubMedCrossRef
287.
Tomaszewski JJ, Sweeney DD, Kavoussi LR, Ost MC. Laparoscopic retroperitoneal lymph node dissection for high-risk pediatric patients with paratesticular rhabdomyosarcoma. J Endourol/Endourol Soc. 2010;24(1):31–4. PubMed.
CrossRef
288.
Heyn R, Raney Jr RB, Hays DM, Tefft M, Gehan E, Webber B, et al. Late effects of therapy in patients with paratesticular rhabdomyosarcoma. Intergroup Rhabdomyosarcoma Study Committee. J Clin Oncol Off J Am Soc Clin Oncol. 1992;10(4):614–23. PubMed Epub 1992/04/11. eng.
289.
Leuschner I, Newton Jr WA, Schmidt D, Sachs N, Asmar L, Hamoudi A, et al. Spindle cell variants of embryonal rhabdomyosarcoma in the paratesticular region. A report of the Intergroup Rhabdomyosarcoma Study. Am J Surg Pathol. 1993;17(3):221–30. PubMed Epub 1993/03/01. eng.
PubMedCrossRef
290.
Stewart RJ, Martelli H, Oberlin O, Rey A, Bouvet N, Spicer RD, et al. Treatment of children with nonmetastatic paratesticular rhabdomyosarcoma: results of the Malignant Mesenchymal Tumors studies (MMT 84 and MMT 89) of the International Society of Pediatric Oncology. J Clin Oncol Off J Am Soc Clin Oncol. 2003;21(5):793–8. PubMed Epub 2003/03/01. eng.
CrossRef
291.
Ferrari A, Bisogno G, Casanova M, Meazza C, Piva L, Cecchetto G, et al. Paratesticular rhabdomyosarcoma: report from the Italian and German Cooperative Group. J Clin Oncol Off J Am Soc Clin Oncol. 2002;20(2):449–55. PubMed Epub 2002/01/12. eng.
CrossRef
292.
Fernandez-Pineda I, Spunt SL, Parida L, Krasin MJ, Davidoff AM, Rao BN. Vaginal tumors in childhood: the experience of St. Jude Children’s Research Hospital. J Pediatr Surg. 2011;46(11):2071–5. PubMed Pubmed Central PMCID: PMC3476720. Epub 2011/11/15. eng.
PubMedPubMedCentralCrossRef
293.
Andrassy RJ. Rhabdomyosarcoma. Semin Pediatr Surg. 1997;6(1):17–23. PubMed Epub 1997/02/01. eng.
PubMed
294.
Andrassy RJ, Hays DM, Raney RB, Wiener ES, Lawrence W, Lobe TE, et al. Conservative surgical management of vaginal and vulvar pediatric rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study III. J Pediatr Surg. 1995;30(7):1034–6; discussion 1036–7. PubMed Epub 1995/07/01. eng.
PubMedCrossRef
295.
Arndt CA, Donaldson SS, Anderson JR, Andrassy RJ, Laurie F, Link MP, et al. What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract? Cancer. 2001;91(12):2454–68. PubMed Epub 2001/06/20. eng.
PubMedCrossRef
296.
Walterhouse DO, Meza JL, Breneman JC, Donaldson SS, Hayes-Jordan A, Pappo AS, et al. Local control and outcome in children with localized vaginal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma committee of the Children’s Oncology Group. Pediatr Blood Cancer. 2011;57(1):76–83. PubMed Pubmed Central PMCID: PMC3459820. Epub 2011/02/08. eng.
PubMedPubMedCentralCrossRef
297.
Breneman J, Meza J, Donaldson SS, Raney RB, Wolden S, Michalski J, et al. Local control with reduced-dose radiotherapy for low-risk rhabdomyosarcoma: a report from the Children’s Oncology Group D9602 study. Int J Radiat Oncol Biol Phys. 2012;83(2):720–6. PubMed Pubmed Central PMCID: PMC3305826. Epub 2011/11/23. eng.
PubMedPubMedCentralCrossRef
298.
Spunt SL, Sweeney TA, Hudson MM, Billups CA, Krasin MJ, Hester AL. Late effects of pelvic rhabdomyosarcoma and its treatment in female survivors. J Clin Oncol Off J Am Soc Clin Oncol. 2005;23(28):7143–51. PubMed Epub 2005/09/30. eng.
CrossRef
299.
McCarville MB. PET-CT imaging in pediatric oncology. Cancer Imaging Off Publ Int Cancer Imaging Soc. 2009;9:35–43. PubMed Pubmed Central PMCID: PMC2739688. Epub 2009/07/16. eng.
300.
Klem ML, Grewal RK, Wexler LH, Schoder H, Meyers PA, Wolden SL. PET for staging in rhabdomyosarcoma: an evaluation of PET as an adjunct to current staging tools. J Pediatr Hematol Oncol. 2007;29(1):9–14. PubMed Epub 2007/01/19. eng.
PubMedCrossRef
301.
Franzius C, Juergens KU. PET/CT in paediatric oncology: indications and pitfalls. Pediatr Radiol. 2009;39 Suppl 3:446–9. PubMed Epub 2009/05/19. eng.
PubMedCrossRef
302.
Kleis M, Daldrup-Link H, Matthay K, Goldsby R, Lu Y, Schuster T, et al. Diagnostic value of PET/CT for the staging and restaging of pediatric tumors. Eur J Nucl Med Mol Imaging. 2009;36(1):23–36. PubMed Epub 2008/08/23. eng.
PubMedCrossRef
303.
Rao BN, Rodriguez-Galindo C. Local control in childhood extremity sarcomas: salvaging limbs and sparing function. Med Pediatr Oncol. 2003;41(6):584–7.
PubMedCrossRef
304.
La TH, Wolden SL, Su Z, Linardic C, Randall RL, Hawkins DS, et al. Local therapy for rhabdomyosarcoma of the hands and feet: is amputation necessary? A report from the Children’s Oncology Group. Int J Radiat Oncol Biol Phys. 2011;80(1):206–12. PubMed Pubmed Central PMCID: PMC3075377. Epub 2010/07/22. eng.
PubMedPubMedCentralCrossRef
305.
Mandell L, Ghavimi F, LaQuaglia M, Exelby P. Prognostic significance of regional lymph node involvement in childhood extremity rhabdomyosarcoma. Med Pediatr Oncol. 1990;18(6):466–71. PubMed Epub 1990/01/01. eng.
PubMedCrossRef
306.
Paulino AC, Pappo A. Alveolar rhabdomyosarcoma of the extremity and nodal metastasis: Is the in-transit lymphatic system at risk? Pediatr Blood Cancer. 2009;53(7):1332–3. PubMed Epub 2009/08/28. eng.
PubMedCrossRef
307.
Andrassy RJ, Corpron CA, Hays D, Raney RB, Wiener ES, Lawrence Jr W, et al. Extremity sarcomas: an analysis of prognostic factors from the Intergroup Rhabdomyosarcoma Study III. J Pediatr Surg. 1996;31(1):191–6. PubMed Epub 1996/01/01. eng.
PubMedCrossRef
308.
Casanova M, Meazza C, Favini F, Fiore M, Morosi C, Ferrari A. Rhabdomyosarcoma of the extremities: a focus on tumors arising in the hand and foot. Pediatr Hematol Oncol. 2009;26(5):321–31. PubMed Epub 2009/07/07. eng.
PubMedCrossRef
309.
Chui CH, Billups CA, Pappo AS, Rao BN, Spunt SL. Predictors of outcome in children and adolescents with rhabdomyosarcoma of the trunk – the St Jude Children’s Research Hospital experience. J Pediatr Surg. 2005;40(11):1691–5. PubMed Epub 2005/11/18. eng.
PubMedCrossRef
310.
Hayes-Jordan A, Stoner JA, Anderson JR, Rodeberg D, Weiner G, Meyer WH, et al. The impact of surgical excision in chest wall rhabdomyosarcoma: a report from the Children’s Oncology Group. J Pediatr Surg. 2008;43(5):831–6. PubMed Epub 2008/05/20. eng.
PubMedPubMedCentralCrossRef
311.
Young MM, Kinsella TJ, Miser JS, Triche TJ, Glaubiger DL, Steinberg SM, et al. Treatment of sarcomas of the chest wall using intensive combined modality therapy. Int J Radiat. 1989;16(1):49–57. PubMed Epub 1989/01/01. eng.
CrossRef
312.
Ortega JA, Wharam M, Gehan EA, Ragab AH, Crist W, Webber B, et al. Clinical features and results of therapy for children with paraspinal soft tissue sarcoma: a report of the Intergroup Rhabdomyosarcoma Study. J Clin Oncol Off J Am Soc Clin Oncol. 1991;9(5):796–801. PubMed Epub 1991/05/01. eng.
313.
Ruymann FB, Raney Jr RB, Crist WM, Lawrence Jr W, Lindberg RD, Soule EH. Rhabdomyosarcoma of the biliary tree in childhood. A report from the Intergroup Rhabdomyosarcoma Study. Cancer. 1985;56(3):575–81. PubMed Epub 1985/08/01. eng.
PubMedCrossRef
314.
Pollono DG, Tomarchio S, Berghoff R, Drut R, Urrutia A, Cedola J. Rhabdomyosarcoma of extrahepatic biliary tree: initial treatment with chemotherapy and conservative surgery. Med Pediatr Oncol. 1998;30(5):290–3. PubMed Epub 1998/04/17. eng.
PubMedCrossRef
315.
Spunt SL, Lobe TE, Pappo AS, Parham DM, Wharam Jr MD, Arndt C, et al. Aggressive surgery is unwarranted for biliary tract rhabdomyosarcoma. J Pediatr Surg. 2000;35(2):309–16. PubMed Epub 2000/02/29. eng.
PubMedCrossRef
316.
Cecchetto G, Bisogno G, Treuner J, Ferrari A, Mattke A, Casanova M, et al. Role of surgery for nonmetastatic abdominal rhabdomyosarcomas: a report from the Italian and German Soft Tissue Cooperative Groups Studies. Cancer. 2003;97(8):1974–80. PubMed Epub 2003/04/04. eng.
PubMedCrossRef
317.
Blakely ML, Lobe TE, Anderson JR, Donaldson SS, Andrassy RJ, Parham DM, et al. Does debulking improve survival rate in advanced-stage retroperitoneal embryonal rhabdomyosarcoma? J Pediatr Surg. 1999;34(5):736–41; discussion 741–2. PubMed Epub 1999/06/08. eng.
PubMedCrossRef
318.
Raney RB, Stoner JA, Walterhouse DO, Andrassy RJ, Donaldson SS, Laurie F, et al. Results of treatment of fifty-six patients with localized retroperitoneal and pelvic rhabdomyosarcoma: a report from The Intergroup Rhabdomyosarcoma Study-IV, 1991–1997. Pediatr Blood Cancer. 2004;42(7):618–25. PubMed Epub 2004/05/06. eng.
PubMedCrossRef
319.
Blakely ML, Andrassy RJ, Raney RB, Anderson JR, Wiener ES, Rodeberg DA, et al. Prognostic factors and surgical treatment guidelines for children with rhabdomyosarcoma of the perineum or anus: a report of Intergroup Rhabdomyosarcoma Studies I through IV, 1972 through 1997. J Pediatr Surg. 2003;38(3):347–53. PubMed Epub 2003/03/13. eng.
PubMedCrossRef
320.
Mattke AC, Bailey EJ, Schuck A, Dantonello T, Leuschner I, Klingebiel T, et al. Does the time-point of relapse influence outcome in pediatric rhabdomyosarcomas? Pediatr Blood Cancer. 2009;52(7):772–6. PubMed Epub 2009/01/24. eng.
PubMedCrossRef
321.
Malempati S, Rodeberg DA, Donaldson SS, Lyden ER, Anderson JR, Hawkins DS, et al. Rhabdomyosarcoma in infants younger than 1 year: a report from the Children’s Oncology Group. Cancer. 2011;117(15):3493–501. PubMed Pubmed Central PMCID: PMC3140625. Epub 2011/01/26. eng.
PubMedPubMedCentralCrossRef
322.
Joshi D, Anderson JR, Paidas C, Breneman J, Parham DM, Crist W. Age is an independent prognostic factor in rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children’s Oncology Group. Pediatr Blood Cancer. 2004;42(1):64–73. PubMed Epub 2004/01/31. eng.
PubMedCrossRef
323.
Raney RB, Crist WM, Maurer HM, Foulkes MA. Prognosis of children with soft tissue sarcoma who relapse after achieving a complete response. A report from the intergroup rhabdomyosarcoma study I. Cancer. 1983;52(1):44–50.
PubMedCrossRef
324.
Klingebiel T, Pertl U, Hess CF, Jürgens H, Koscielniak E, Pötter R, et al. Treatment of children with relapsed soft tissue sarcoma: Report of the German CESS/CWS REZ 91 Trial. Med Pediatr Oncol. 1998;30(5):269–75.
PubMedCrossRef
325.
Maurer HM, Gehan EA, Beltangady M, Crist W, Dickman PS, Donaldson SS, et al. The Intergroup Rhabdomyosarcoma Study-II. Cancer. 1993;71(5):1904–22. PubMed Epub 1993/03/01. eng.
PubMedCrossRef